183 related articles for article (PubMed ID: 38330198)
21. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
[TBL] [Abstract][Full Text] [Related]
22. IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis.
Campbell RA; Manne BK; Banerjee M; Middleton EA; Ajanel A; Schwertz H; Denorme F; Stubben C; Montenont E; Saperstein S; Page L; Tolley ND; Lim DL; Brown SM; Grissom CK; Sborov DW; Krishnan A; Rondina MT
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36194487
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules.
Handagama PJ; Shuman MA; Bainton DF
J Clin Invest; 1989 Jul; 84(1):73-82. PubMed ID: 2738161
[TBL] [Abstract][Full Text] [Related]
24. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules.
Handagama P; Bainton DF; Jacques Y; Conn MT; Lazarus RA; Shuman MA
J Clin Invest; 1993 Jan; 91(1):193-200. PubMed ID: 8423218
[TBL] [Abstract][Full Text] [Related]
25. A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation.
Wang C; Tu Z; Cai X; Wang W; Davis AK; Nattamai K; Paranjpe A; Dexheimer P; Wu J; Huang FL; Geiger H; Huang G; Zheng Y
Blood Adv; 2023 Jun; 7(11):2590-2605. PubMed ID: 36661340
[TBL] [Abstract][Full Text] [Related]
26. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
[TBL] [Abstract][Full Text] [Related]
27. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.
Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
Blood Adv; 2024 Jan; 8(2):497-511. PubMed ID: 38019014
[TBL] [Abstract][Full Text] [Related]
28. Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation.
Krutein MC; Hart MR; Anderson DJ; Jeffery J; Kotini AG; Dai J; Chien S; DelPriore M; Borst S; Maguire JA; French DL; Gadue P; Papapetrou EP; Keel SB; Becker PS; Horwitz MS
Blood Adv; 2021 Feb; 5(3):687-699. PubMed ID: 33560381
[TBL] [Abstract][Full Text] [Related]
29. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.
Antony-Debré I; Bluteau D; Itzykson R; Baccini V; Renneville A; Boehlen F; Morabito M; Droin N; Deswarte C; Chang Y; Leverger G; Solary E; Vainchenker W; Favier R; Raslova H
Blood; 2012 Sep; 120(13):2719-22. PubMed ID: 22677128
[TBL] [Abstract][Full Text] [Related]
30. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
[TBL] [Abstract][Full Text] [Related]
31. Arf6 controls platelet spreading and clot retraction via integrin αIIbβ3 trafficking.
Huang Y; Joshi S; Xiang B; Kanaho Y; Li Z; Bouchard BA; Moncman CL; Whiteheart SW
Blood; 2016 Mar; 127(11):1459-67. PubMed ID: 26738539
[TBL] [Abstract][Full Text] [Related]
32. Cellubrevin/vesicle-associated membrane protein-3-mediated endocytosis and trafficking regulate platelet functions.
Banerjee M; Joshi S; Zhang J; Moncman CL; Yadav S; Bouchard BA; Storrie B; Whiteheart SW
Blood; 2017 Dec; 130(26):2872-2883. PubMed ID: 28931526
[TBL] [Abstract][Full Text] [Related]
33. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
[TBL] [Abstract][Full Text] [Related]
34. Myeloid neoplasms with germ line RUNX1 mutation.
Hayashi Y; Harada Y; Huang G; Harada H
Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
[TBL] [Abstract][Full Text] [Related]
35. RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells.
Estevez B; Borst S; Jarocha D; Sudunagunta V; Gonzalez M; Garifallou J; Hakonarson H; Gao P; Tan K; Liu P; Bagga S; Holdreith N; Tong W; Speck N; French DL; Gadue P; Poncz M
Blood; 2021 May; 137(19):2662-2675. PubMed ID: 33569577
[TBL] [Abstract][Full Text] [Related]
36. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
[No Abstract] [Full Text] [Related]
37. Measurement of endogenous and exogenous alpha-granular platelet proteins in patients with immune and nonimmune thrombocytopenia.
Hughes M; Hayward CP; Horsewood P; Warkentin TE; Kelton JG
Br J Haematol; 1999 Sep; 106(3):762-70. PubMed ID: 10468871
[TBL] [Abstract][Full Text] [Related]
38. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
[No Abstract] [Full Text] [Related]
39. Human
Li Y; Jin C; Bai H; Gao Y; Sun S; Chen L; Qin L; Liu PP; Cheng L; Wang QF
Blood; 2018 Jan; 131(2):191-201. PubMed ID: 29101237
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
